Skip to main content
Equibles

WELLS FARGO & COMPANY/MN

Position in KYTX — Kyverna Therapeutics, Inc.

CIK 72971 SAN FRANCISCO, CA
Back to KYTX Full portfolio

Position in KYTX

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$3,323,509
+$2,336,246 QoQ
Shares Held
373,009
+226.1% QoQ
Ownership
0.603%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#19
of 120 holders
Holding Since
Mar 2024
10 quarters on record
Voting authority Sole 94% Shared 0% None 6%

Common Shares in KYTX Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

WELLS FARGO & COMPANY/MN holds $1,575,562,942 across 417 Biotechnology names. KYTX ranks #76 (0.2% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 VRTX
Vertex Pharmaceuticals Inc / Ma
 749,528 $372,313,040
2 HALO
Halozyme Therapeutics, Inc.
 1,390,428 $108,828,797
3 ALNY
Alnylam Pharmaceuticals, Inc.
 310,047 $93,333,446
4 REGN
Regeneron Pharmaceuticals, Inc.
 140,802 $87,795,677
5 EXEL
Exelixis, Inc.
 717,840 $39,057,673
6 RVMD
Revolution Medicines, Inc.
 178,780 $33,481,916
7 ARGX
Argenx SE
 34,453 $31,964,458
8 INCY
Incyte Corp
 255,064 $28,914,053

All Filings in KYTX

Export CSV
10 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $3,323,509 373,009
2026-03-31 $987,263 114,399
2025-12-31 $704,520 74,949
2025-09-30 $109,680 18,280
2025-06-30 $10,228 3,332
2025-03-31 $32,188 16,678
2024-12-31 $669,503 179,012
2024-09-30 $752,017 153,787
2024-06-30 $845,317 112,709
2024-03-31 $295,744 11,906